Bristol-Myers Squibb Company - SWOT, Strategy and Corporate Finance Report

Date: July 2, 2013
Pages: 74
Price:
US$ 175.00
License [?]:
Publisher: MarketLine
Report type: Company Report
Delivery: E-mail Delivery (PDF)
ID: B52CAFB989EEN
Leaflet:

Download PDF Leaflet

Bristol-Myers Squibb Company - SWOT, Strategy and Corporate Finance Report
Bristol-Myers Squibb Company - SWOT, Strategy and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings, detailed financials, and corporate actions, providing a 360˚ view of the company.

Features:
  • Detailed information on Bristol-Myers Squibb Company required for business and competitor intelligence needs
  • A study of the major internal and external factors affecting Bristol-Myers Squibb Company in the form of a SWOT analysis
  • An in-depth view of the business model of Bristol-Myers Squibb Company including a breakdown and examination of key business segments
  • Five-year financial information and charts, including balance sheet, income statement, cash flows, market capitalization and multiples, and key ratios for Bristol-Myers Squibb Company
  • Intelligence on Bristol-Myers Squibb Companynv’s mergers and acquisitions (M&A), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
  • News about Bristol-Myers Squibb Company, such as business expansion, restructuring, and contract wins
  • Large number of easy-to-grasp charts and graphs that present important data and key trends
Highlights:

Bristol-Myers Squibb Company (BMS or 'the company') is a global biopharmaceutical company. BMS was formed by the merger of Bristol Myers and Squibb Pharmaceuticals in 1989, a move which at the time created the world's second largest drug company. The company has its operations in the Americas, Europe, Japan, Asia, Australia, the Middle East and Africa. BMS is headquartered in New York City, New York, and employed 28,000 people as of December 31, 2012. The company recorded revenues of $17,621 million during the financial year ended December 2012 (FY2012), a decrease of 17.1% over FY2011. The operating profit of the company was $2,340 million in FY2012, a decrease of 66.5% over FY2011. The net profit was $1,960 million in FY2012, a decrease of 47.2% over FY2011.

Reasons to Purchase:
  • Gain understanding of Bristol-Myers Squibb Company and the factors that influence its strategies
  • Track strategic initiatives of the company and latest corporate news and actions
  • Assess Bristol-Myers Squibb Company as a prospective partner, vendor or supplier
  • Support sales activities by understanding your customers' businesses better
  • Stay up to date on Bristol-Myers Squibb Company’s business structure, strategy and prospects
COMPANY SNAPSHOT

Bristol-Myers Squibb Company: Company Overview
Bristol-Myers Squibb Company: Overview and Key Facts
  Bristol-Myers Squibb Company: Overview
  Bristol-Myers Squibb Company: Key Facts
Bristol-Myers Squibb Company: Key Employees
Bristol-Myers Squibb Company: Key Employee Biographies
Bristol-Myers Squibb Company: Major Products and Services
Bristol-Myers Squibb Company: Company History
Bristol-Myers Squibb Company: Management Statement
Bristol-Myers Squibb Company: Locations and Subsidiaries
Bristol-Myers Squibb Company: Key Competitors

BRISTOL-MYERS SQUIBB COMPANY: COMPANY ANALYSIS

Bristol-Myers Squibb Company: Business Description
Bristol-Myers Squibb Company: SWOT Analysis
  Bristol-Myers Squibb Company: SWOT Overview
  Bristol-Myers Squibb Company: Strengths
  Bristol-Myers Squibb Company: Weaknesses
  Bristol-Myers Squibb Company: Opportunities
  Bristol-Myers Squibb Company: Threats
Bristol-Myers Squibb Company: Financial Analysis
  Bristol-Myers Squibb Company: Financial Overview
  Bristol-Myers Squibb Company: Five Year Company Financials
  Bristol-Myers Squibb Company: Key Income Statement Data
  Bristol-Myers Squibb Company: Key Balance Sheet Data
  Bristol-Myers Squibb Company: Key Cash Flow Data
  Bristol-Myers Squibb Company: Key Market Data
  Bristol-Myers Squibb Company: Valuation Ratios
  Bristol-Myers Squibb Company: Profitability Ratios
  Bristol-Myers Squibb Company: Management Efficiency Ratios
  Bristol-Myers Squibb Company: Financial Strength Ratios
  Bristol-Myers Squibb Company: Operational Efficiency Ratios
  Bristol-Myers Squibb Company: Others
Bristol-Myers Squibb Company: Corporate Financial Deals Activity
Bristol-Myers Squibb Company: Financial Deals Overview
Bristol-Myers Squibb Company: Targets and Partners
Bristol-Myers Squibb Company: Top Deals 2009 - 2013YTD
Bristol-Myers Squibb Company: Advisors
  Bristol-Myers Squibb Company: Top Legal Advisors
  Bristol-Myers Squibb Company: Top Financial Advisors
Bristol-Myers Squibb Company: Mergers and Acquisitions
Bristol-Myers Squibb Company: Corporate Venturing
Bristol-Myers Squibb Company: Partnership
Bristol-Myers Squibb Company: Divestments

BRISTOL-MYERS SQUIBB COMPANY: RECENT DEVELOPMENTS

Bristol-Myers Squibb Company: News and Events Summary
Bristol-Myers Squibb Company: Contracts
Bristol-Myers Squibb Company: Financial Performance
Bristol-Myers Squibb Company: Regulatory and Legal Events
Bristol-Myers Squibb Company: Research & Development

APPENDIX

Contact Us
Methodology
Definitions
About Datamonitor

LIST OF TABLES

Table 1: Bristol-Myers Squibb Company: Key Facts
Table 2: Bristol-Myers Squibb Company: Key Employees
Table 4: Bristol-Myers Squibb Company: Key Competitors
Table 5: Bristol-Myers Squibb Company: Key Income Statement Data
Table 6: Bristol-Myers Squibb Company: Key Balance Sheet Data
Table 7: Bristol-Myers Squibb Company: Key Cash Flow Data
Table 8: Bristol-Myers Squibb Company: Key Market Data
Table 9: Bristol-Myers Squibb Company: Key Growth Ratios
Table 10: Bristol-Myers Squibb Company: Valuation Ratios
Table 11: Bristol-Myers Squibb Company: Profitability Ratios
Table 12: Bristol-Myers Squibb Company: Management Efficiency Ratios
Table 13: Bristol-Myers Squibb Company: Financial Strength Ratios
Table 14: Bristol-Myers Squibb Company: Operational Efficiency Ratios
Table 15: Bristol-Myers Squibb Company: Others
Table 16: Bristol-Myers Squibb Company: Deal Activity by Deal Type - Volume (TTM*)
Table 17: Bristol-Myers Squibb Company: M&A Activity by Geography (TTM*)
Table 18: Bristol-Myers Squibb Company: Deal Activity by Deal Type - Volume (2009 - YTD 2013)
Table 19: Bristol-Myers Squibb Company: M&A Average Deal Size - Value (US$m)
Table 20: Bristol-Myers Squibb Company: Targets and Partners
Table 21: Bristol-Myers Squibb Company: Top Deals 2009 - 2013YTD
Table 22: Bristol-Myers Squibb Company: Legal Advisor Ranking by Value (US$m)
Table 23: Bristol-Myers Squibb Company: Financial Advisor Ranking by Value (US$m)
Table 24: Bristol-Myers Squibb Company: M&A Volume and Value Trend (2009 - YTD 2013)
Table 25: Bristol-Myers Squibb Company: M&A Activity by Geography (2009 - YTD 2013)
Table 26: Bristol-Myers Squibb Company: Corporate Venturing Volume and Value Trend (2009 - YTD 2013)
Table 27: Bristol-Myers Squibb Company: Corporate Venturing by Geography (2009 - YTD 2013)
Table 28: Bristol-Myers Squibb Company: Partnership Volume and Value Trend (2009 - YTD 2013)
Table 29: Bristol-Myers Squibb Company: Partnership Trend by Deal Type (2009 - YTD 2013)
Table 30: Bristol-Myers Squibb Company: Divestments Volume and Value Trend (2009 - YTD 2013)
Table 31: Bristol-Myers Squibb Company: Divestments by Geography (2009 - YTD 2013)
Table 32: Bristol-Myers Squibb Company: News and Events Summary
Table 33: Bristol-Myers Squibb Company: Contracts
Table 34: Bristol-Myers Squibb Company: Financial Performance
Table 35: Bristol-Myers Squibb Company: Regulatory and Legal Events
Table 36: Bristol-Myers Squibb Company: Research & Development

LIST OF FIGURES

Figure 1: Bristol-Myers Squibb Company: Revenue to Net Income (2007-2011)
Figure 2: Bristol-Myers Squibb Company: Revenue/Employee to Net Income/Employee (2007-2011)
Figure 3: Bristol-Myers Squibb Company: Current Assets to Current Liabilities (2007-2011)
Figure 4: Bristol-Myers Squibb Company: Assets, Liabilities to Total Equity (2007-2011)
Figure 5: Bristol-Myers Squibb Company: Free Cash Flow to Cash from Operating Activities (2007-2011)
Figure 6: Bristol-Myers Squibb Company: Net Change in Cash (2007-2011)
Figure 7: Bristol-Myers Squibb Company: Market Capitalization to Year-end Share Price (2007-2011)
Figure 8: Bristol-Myers Squibb Company: Enterprise Value (2007-2011)
Figure 9: Bristol-Myers Squibb Company: Deal Activity by Deal Type - Volume (TTM*)
Figure 10: Bristol-Myers Squibb Company: M&A Activity by Geography (TTM*)
Figure 11: Bristol-Myers Squibb Company: Deal Activity by Deal Type - Volume (2009 - YTD 2013)
Figure 12: Bristol-Myers Squibb Company: M&A Average Deal Size - Value (US$m)
Figure 13: Bristol-Myers Squibb Company: M&A Volume and Value Trend (2009 - YTD 2013)
Figure 14: Bristol-Myers Squibb Company: M&A Activity by Geography (2009 - YTD 2013)
Figure 15: Bristol-Myers Squibb Company: Corporate Venturing Volume and Value Trend (2009 - YTD 2013)
Figure 16: Bristol-Myers Squibb Company: Corporate Venturing by Geography (2009 - YTD 2013)
Figure 17: Bristol-Myers Squibb Company: Partnership Volume and Value Trend (2009 - YTD 2013)
Figure 18: Bristol-Myers Squibb Company: Partnership Trend by Deal Type (2009 - YTD 2013)
Figure 19: Bristol-Myers Squibb Company: Divestments Volume and Value Trend (2009 - YTD 2013)
Figure 20: Bristol-Myers Squibb Company: Divestments by Geography (2009 - YTD 2013)

Ask Your Question

Bristol-Myers Squibb Company - SWOT, Strategy and Corporate Finance Report
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry: